Establishment of a Human Induced Pluripotent Stem Cell Line (Csuasoi010-A) by Reprogramming Peripheral Blood Mononuclear Cells of a Type 2 Diabetic Mellitus Patient.
Chengcheng Ding,Feng Tan,Yalan Zhou,Chunwen Duan,Jianing Gu,Zekai Cui,Zhongping Chen,Shibo Tang,Jiansu Chen
DOI: https://doi.org/10.1016/j.scr.2022.102851
IF: 1.587
2022-01-01
Stem Cell Research
Abstract:Type 2 diabetes mellitus (T2DM) is a major caused by insulin resistance with a relative deficiency in insulin secretion. Statistically, T2DM accounts for 90% of diabetes cases worldwide. We report the patient-specific human induced pluripotent stem cell line (iPSC) CSUASOi010-A by using Peripheral blood mononuclear cells (PBMCs) of a 62-year-old female from Type 2 diabetes mellitus (T2DM). Patient blood-derived cells were reprogrammed using the Sendai virus.
What problem does this paper attempt to address?